[1]
“TIRZEPATIDE FOR CARDIOVASCULAR RISK REDUCTION: A LITERATURE REVIEW”, IJITSS, vol. 5, no. 3(47), Nov. 2025, doi: 10.31435/ijitss.3(47).2025.3989.